Efficacy of Rezafungin in Prophylactic Mouse Models of Invasive Candidiasis, Aspergillosis, and Pneumocystis Pneumonia

Antifungal prophylaxis is recommended to prevent invasive fungal disease caused by Candida spp., Aspergillus spp., and Pneumocystis jirovecii in patients at risk for opportunistic infections, such as allogeneic blood or marrow transplant recipients, patients with hematological disease undergoing che...

Descripción completa

Detalles Bibliográficos
Autores principales: Miesel, Lynn, Cushion, Melanie T., Ashbaugh, Alan, Lopez, Santiago R., Ong, Voon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092522/
https://www.ncbi.nlm.nih.gov/pubmed/33318018
http://dx.doi.org/10.1128/AAC.01992-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092522/
https://www.ncbi.nlm.nih.gov/pubmed/33318018
http://dx.doi.org/10.1128/AAC.01992-20

Ejemplares similares